CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 盐酸雷尼替丁Ranitidine Hydrochloride
Ranitidine Hydrochloride

盐酸雷尼替丁 杂质对照品Ranitidine Hydrochloride Impurities

EP33 个杂质条目33 impurity entries

本页汇总 盐酸雷尼替丁 的 33 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 33 impurity reference standards of Ranitidine Hydrochloride with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 盐酸雷尼替丁(Ranitidine Hydrochloride)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesN-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride
    Chemical & pharmaceutical bulletin · 2021 · Yokoo H et al.  ·  PMID 34470951  ·  DOI
  2. 杂质研究Impurity studiesOptimisation, validation and application of a capillary electrophoresis method for the determination of ranitidine hydrochloride and related substances
    Journal of chromatography. A · 1998 · Kelly MA et al.  ·  PMID 9542141  ·  DOI
  3. 杂质研究Impurity studiesA validated stability-indicating liquid-chromatographic method for ranitidine hydrochloride in liquid oral dosage form
    Scientia pharmaceutica · 2011 · Sharma N et al.  ·  PMID 21773068  ·  DOI
  4. 分析方法Analytical MethodsValidation of four different spectrophotometric methods for simultaneous determination of Domperidone and Ranitidine in bulk and pharmaceutical formulation
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2015 · Abdel-Ghany MF et al.  ·  PMID 25942082  ·  DOI
  5. 分析方法Analytical MethodsUtility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form, in dosage forms and in the presence of its oxidative degradates
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2003 · Amin AS et al.  ·  PMID 12609617  ·  DOI

盐酸雷尼替丁 —— 原料药与杂质对照品Ranitidine Hydrochloride — drug substance & impurities

共 33 个条目(含原料药本体)33 items incl. the drug substance
Ranitidine Hydrochloride structure
EP原料药 APIAPI
盐酸雷尼替丁Ranitidine Hydrochloride
Ranitidine Hydrochloride
CAS No.66357-59-3
Chemical FormulaC13H22N4O3S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 1 (Ranitidine Hydrochloride EP Impurity A) structure
EPA
盐酸雷尼替丁杂质1 (盐酸雷尼替丁EP杂质A)Ranitidine Hydrochloride Impurity 1 (Ranitidine Hydrochloride EP Impurity A)
Ranitidine Hydrochloride Impurity 1 (Ranitidine Hydrochloride EP Impurity A)
CAS No.72126-78-4
Chemical FormulaC22H35N5O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 2 Hemifumarate (Ranitidine Hydrochloride EP Impurity B Hemifumarate) (Ranitidine USP Related Compound A) structure
EPB
盐酸雷尼替丁杂质2 半富马酸盐 (盐酸雷尼替丁EP杂质B 半富马酸盐) (雷尼替丁USP相关化合物A)Ranitidine Hydrochloride Impurity 2 Hemifumarate (Ranitidine Hydrochloride EP Impurity B Hemifumarate) (Ranitidine USP Related Compound A)
Ranitidine Hydrochloride Impurity 2 Hemifumarate (Ranitidine Hydrochloride EP Impurity B Hemifumarate) (Ranitidine USP Related Compound A)
CAS No.256948-32-0
Chemical FormulaC10H18N2OS·1/2(C4H4O4)
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 2 (Ranitidine Hydrochloride EP Impurity B) (Ranitidine USP Related Compound A) structure
EPB
盐酸雷尼替丁杂质2 (盐酸雷尼替丁EP杂质B) (雷尼替丁USP相关化合物A)Ranitidine Hydrochloride Impurity 2 (Ranitidine Hydrochloride EP Impurity B) (Ranitidine USP Related Compound A)
Ranitidine Hydrochloride Impurity 2 (Ranitidine Hydrochloride EP Impurity B) (Ranitidine USP Related Compound A)
CAS No.66356-53-4
Chemical FormulaC10H18N2OS
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 3 (Ranitidine Hydrochloride EP Impurity C) structure
EPC
盐酸雷尼替丁杂质3 (盐酸雷尼替丁EP杂质C)Ranitidine Hydrochloride Impurity 3 (Ranitidine Hydrochloride EP Impurity C)
Ranitidine Hydrochloride Impurity 3 (Ranitidine Hydrochloride EP Impurity C)
CAS No.73851-70-4
Chemical FormulaC13H22N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 4 (Ranitidine Hydrochloride EP Impurity D) structure
EPD
盐酸雷尼替丁杂质4 (盐酸雷尼替丁EP杂质D)Ranitidine Hydrochloride Impurity 4 (Ranitidine Hydrochloride EP Impurity D)
Ranitidine Hydrochloride Impurity 4 (Ranitidine Hydrochloride EP Impurity D)
CAS No.117846-02-3
Chemical FormulaC12H19N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 5 (Ranitidine Hydrochloride EP Impurity E) structure
EPE
盐酸雷尼替丁杂质5 (盐酸雷尼替丁EP杂质E)Ranitidine Hydrochloride Impurity 5 (Ranitidine Hydrochloride EP Impurity E)
Ranitidine Hydrochloride Impurity 5 (Ranitidine Hydrochloride EP Impurity E)
CAS No.73857-20-2
Chemical FormulaC13H22N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 6 (Ranitidine Hydrochloride EP Impurity F) structure
EPF
盐酸雷尼替丁杂质6 (盐酸雷尼替丁EP杂质F)Ranitidine Hydrochloride Impurity 6 (Ranitidine Hydrochloride EP Impurity F)
Ranitidine Hydrochloride Impurity 6 (Ranitidine Hydrochloride EP Impurity F)
CAS No.15433-79-1
Chemical FormulaC8H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 8 (Ranitidine Hydrochloride EP Impurity H) structure
EPH
盐酸雷尼替丁杂质8 (盐酸雷尼替丁EP杂质H)Ranitidine Hydrochloride Impurity 8 (Ranitidine Hydrochloride EP Impurity H)
Ranitidine Hydrochloride Impurity 8 (Ranitidine Hydrochloride EP Impurity H)
CAS No.72078-82-1
Chemical FormulaC3H6N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 9 (Ranitidine Hydrochloride EP Impurity I) structure
EPI
盐酸雷尼替丁杂质9 (盐酸雷尼替丁EP杂质I)Ranitidine Hydrochloride Impurity 9 (Ranitidine Hydrochloride EP Impurity I)
Ranitidine Hydrochloride Impurity 9 (Ranitidine Hydrochloride EP Impurity I)
CAS No.207592-21-0
Chemical FormulaC27H44N8O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 10 (Ranitidine Hydrochloride EP Impurity J) structure
EPJ
盐酸雷尼替丁杂质10 (盐酸雷尼替丁EP杂质J)Ranitidine Hydrochloride Impurity 10 (Ranitidine Hydrochloride EP Impurity J)
Ranitidine Hydrochloride Impurity 10 (Ranitidine Hydrochloride EP Impurity J)
CAS No.1331637-48-9
Chemical FormulaC11H22N6O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride-d6 structure
—
盐酸雷尼替丁-d6Ranitidine Hydrochloride-d6
Ranitidine Hydrochloride-d6
CAS No.1185238-09-8
Chemical FormulaC13H16D6N4O3S·HCl
Purity>95%询价On request
Ranitidine-d6 structure
—
雷尼替丁-d6Ranitidine-d6
Ranitidine-d6
CAS No.1185514-83-3
Chemical FormulaC13H16D6N4O3S
Purity>95%询价On request
Ranitidine structure
—
雷尼替丁Ranitidine
Ranitidine
CAS No.66357-35-5
Chemical FormulaC13H22N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 12 structure
12
盐酸雷尼替丁杂质12Ranitidine Hydrochloride Impurity 12
Ranitidine Hydrochloride Impurity 12
CAS No.1823006-39-8
Chemical FormulaC6H8O4
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 15 structure
15
盐酸雷尼替丁杂质15Ranitidine Hydrochloride Impurity 15
Ranitidine Hydrochloride Impurity 15
CAS No.112233-24-6
Chemical FormulaC13H20N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 16 structure
16
盐酸雷尼替丁杂质16Ranitidine Hydrochloride Impurity 16
Ranitidine Hydrochloride Impurity 16
CAS No.112233-25-7
Chemical FormulaC21H33N5O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 17 structure
17
盐酸雷尼替丁杂质17Ranitidine Hydrochloride Impurity 17
Ranitidine Hydrochloride Impurity 17
CAS No.66357-41-3
Chemical FormulaC5H11N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 18 structure
18
盐酸雷尼替丁杂质18Ranitidine Hydrochloride Impurity 18
Ranitidine Hydrochloride Impurity 18
CAS No.112251-56-6
Chemical FormulaC12H18N3NaO4S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 19 structure
19
盐酸雷尼替丁杂质19Ranitidine Hydrochloride Impurity 19
Ranitidine Hydrochloride Impurity 19
CAS No.72115-14-1
Chemical FormulaC13H21N3O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 21 structure
21
盐酸雷尼替丁杂质21Ranitidine Hydrochloride Impurity 21
Ranitidine Hydrochloride Impurity 21
CAS No.113224-25-2
Chemical FormulaC5H10N2O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 22 structure
22
盐酸雷尼替丁杂质22Ranitidine Hydrochloride Impurity 22
Ranitidine Hydrochloride Impurity 22
CAS No.871-76-1
Chemical FormulaC4H13ClN2S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 23 structure
23
盐酸雷尼替丁杂质23Ranitidine Hydrochloride Impurity 23
Ranitidine Hydrochloride Impurity 23
CAS No.82301-45-9
Chemical FormulaC8H12ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 26 structure
26
盐酸雷尼替丁杂质26Ranitidine Hydrochloride Impurity 26
Ranitidine Hydrochloride Impurity 26
CAS No.14697-46-2
Chemical FormulaC5H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 27 structure
27
盐酸雷尼替丁杂质27Ranitidine Hydrochloride Impurity 27
Ranitidine Hydrochloride Impurity 27
CAS No.156-57-0
Chemical FormulaC2H7NS·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 28 structure
28
盐酸雷尼替丁杂质28Ranitidine Hydrochloride Impurity 28
Ranitidine Hydrochloride Impurity 28
CAS No.1197-40-6
Chemical FormulaC9H8O2
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 29 structure
29
盐酸雷尼替丁杂质29Ranitidine Hydrochloride Impurity 29
Ranitidine Hydrochloride Impurity 29
CAS No.1263378-39-7
Chemical FormulaC7H7NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 30 structure
30
盐酸雷尼替丁杂质30Ranitidine Hydrochloride Impurity 30
Ranitidine Hydrochloride Impurity 30
CAS No.5904-71-2
Chemical FormulaC7H6O4
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 31 structure
31
盐酸雷尼替丁杂质31Ranitidine Hydrochloride Impurity 31
Ranitidine Hydrochloride Impurity 31
CAS No.617-88-9
Chemical FormulaC5H5ClO
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 32 structure
32
盐酸雷尼替丁杂质32Ranitidine Hydrochloride Impurity 32
Ranitidine Hydrochloride Impurity 32
CAS No.14497-29-1
Chemical FormulaC5H5ClO
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 33 structure
33
盐酸雷尼替丁杂质33Ranitidine Hydrochloride Impurity 33
Ranitidine Hydrochloride Impurity 33
CAS No.463-00-3
Chemical FormulaC5H11N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 34 (Mixture of E/Z-isomers) structure
34
盐酸雷尼替丁杂质34 (混合E/Z构型)Ranitidine Hydrochloride Impurity 34 (Mixture of E/Z-isomers)
Ranitidine Hydrochloride Impurity 34 (Mixture of E/Z-isomers)
CAS No.764604-04-8
Chemical FormulaC15H26N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ranitidine Hydrochloride Impurity 41 structure
41
盐酸雷尼替丁杂质41Ranitidine Hydrochloride Impurity 41
Ranitidine Hydrochloride Impurity 41
CAS No.13493-97-5
Chemical FormulaC6H6O3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

盐酸雷尼替丁 —— 研究文献与合成路线Ranitidine Hydrochloride — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 盐酸雷尼替丁 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ranitidine Hydrochloride. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability indicating spectrodensitometric determination of ranitidine hydrochloride using linear and non-linear regression
    El-Bayoumi AE, El-Shanawany A, El-Sadek ME, et al. · Journal of pharmaceutical and biomedical analysis · 1999 · 被引 7cited 7
  2. N-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride
    Yokoo H, Yamamoto E, Masada S, et al. · Chemical & pharmaceutical bulletin · 2021 · 被引 16cited 16
  3. Utility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form, in dosage forms and in the presence of its oxidative degradates
    Amin AS, Ahmed IS, Dessouki HA, et al. · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2003 · 被引 6cited 6
  4. Chromatographic methods for determining the identity, strength and purity of ranitidine hydrochloride both in the drug substance and its dosage forms--an exercise in method selection, development, definition and validation
    Evans MB, Haywood PA, Johnson D, et al. · Journal of pharmaceutical and biomedical analysis · 1989 · 被引 14cited 14
  5. Determination of ranitidine hydrochloride in pharmaceutical preparations by titrimetry and visible spectrophotometry using bromate and acid dyes
    Basavaiah K, Nagegowda P · Farmaco (Societa chimica italiana : 1989) · 2004 · 被引 6cited 6

合成与制备工艺专利Synthesis & process patents

  1. Novel process for the preparation of form 1 ranitidine hydrochloride
    CHENG WEN J, BRIGGS ROGER L, MCCOY LEE V · 公开号 US2004267030US2004267030 · 2004
  2. PROCESS FOR THE PREPARATION OF FORM 1 RANITIDINE HYDROCHLORIDE
    CHENG WEN J, BRIGGS ROGER L, MCCOY LEE V · 公开号 WO9735853WO9735853 · 1997
  3. A PROCESS FOR PREPARING FORM 1 RANITIDINE HYDROCHLORIDE
    SCHICKANEDER HELMUT, NIKOLOPOULOS AGGELOS · 公开号 WO9633185WO9633185 · 1996
  4. Process for the manufacture of form 1 ranitidine hydrochloride
    Khanna Jag Mohan 74 Asian Games Village Complex, Kumar Naresh 121 South Park, Khera Brij, Khanna Mahavir Singh · 公开号 EP0694540EP0694540 · 1996
  5. CRYSTALLINE CYCLODEXTRIN INCLUSION COMPLEXES OF RANITIDINE HYDROCHLORIDE AND PROCESS FOR THEIR PREPARATION
    FISCHER Wilfried, KLOKKERS Karin · 公开号 EP0687174EP0687174 · 1995

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

盐酸雷尼替丁 杂质谱研究要点Ranitidine Hydrochloride — impurity profiling notes

下面这些是拿到 盐酸雷尼替丁 的 33 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 33 impurity entries for Ranitidine Hydrochloride, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances